Skip to main content

Lifevantage Corp

LFVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000849146

In the last 90 days, Lifevantage Corp insiders filed 1 open-market purchase and 1 sale; 88 institutions reported holding it in 13F filings for Q2 2026, worth $36.9M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Lifevantage Corp changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of LFVN: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders4844−4
Shares3.10M2.95M−156.7K (−5.0%)
Value$11.6M$11.0M−$691.9K (−5.9%)

New holders (4)

Institutions that held Lifevantage Corp at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to LFVN in Q4 2022
InstitutionSharesValue% of portfolio
Citadel Advisors LLC32,263$120.0K0.00%
Susquehanna International Group, LLP24,945$92.8K0.00%
ICA Group Wealth Management, LLC51$1900.00%
GWM Advisors LLC1,257$50.00%

Sold out (8)

Institutions that held Lifevantage Corp at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of LFVN in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
State of Tennessee, Treasury Department23,974$90.0K
O'Shaughnessy Asset Management, LLC18,622$70.0K
Campbell & CO Investment Adviser LLC12,813$48.0K
Victory Capital Management Inc11,504$43.0K
Private Advisor Group, LLC11,200$42.0K
JPMorgan Chase & Co7,129$27.0K
Credit Suisse AG3,900$15.0K
Professional Financial Advisors, LLC2,555$10.0K